Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma

The effects of recombinant tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on B16 mouse melanoma experimental metastatic ability and major histocompatibility complex (H-2b) antigens expression were studied. B16 cells exposed in vitro to TNF-alpha had an increased H-2 expression and were more metastatic than untreated cells. The simultaneous treatment with TNF-alpha and IFN-gamma amplified the enhancement of experimental metastasis and all other effects obtained with TNF-alpha alone. The B16 clone B78H1, selectively resistant to H-2 induction and to enhancement of metastatic ability by IFN-gamma, was not affected by treatment with TNF-alpha and with TNF-alpha + IFN-gamma. These findings contribute to a better understanding of the pleiotropic effects of TNF, some of which can have opposing actions in the complex tumor-host relationships.[/p]

[1]  M. Zöller,et al.  Interferon‐gamma treatment of B16 melanoma cells: Opposing effects for non‐adaptive and adaptive immune defense and its reflection by metastatic spread , 1988, International journal of cancer.

[2]  J. Talmadge,et al.  Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. , 1985, Journal of immunology.

[3]  F. Balkwill,et al.  Enhanced metastases of a mouse carcinoma after in vitro treatment with murine interferon gamma , 1987, International journal of cancer.

[4]  P. Lollini,et al.  Interferon-mediated modulation of metastasis and MHC antigens. , 1988, Advances in experimental medicine and biology.

[5]  R. Burton,et al.  Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. , 1981, Journal of immunology.

[6]  P. Scheurich,et al.  Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. , 1987, Journal of immunology.

[7]  J. Talmadge,et al.  Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. , 1987, Cancer research.

[8]  S. Segal,et al.  NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells. , 1988, Advances in experimental medicine and biology.

[9]  H. Wexler.  Accurate identification of experimental pulmonary metastases. , 1966, Journal of the National Cancer Institute.

[10]  G. Wong,et al.  Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.

[11]  S. Segal,et al.  The differential expression of H‐2K versus H‐2D antigens, distinguishing high‐ metastatic from low‐ metastatic clones, is correlated with the immunogenic properties of the tumor cells , 1984, International journal of cancer.

[12]  S. Segal,et al.  Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells. , 1988, Immunology letters.

[13]  K. Nomoto,et al.  Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes. , 1986, Journal of immunology.

[14]  G. Klein,et al.  Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. McMillan,et al.  Interferon‐induced alterations in metastatic capacity, class‐1 antigen expression and natural killer cell sensitivity of melanoma cells , 1987, International journal of cancer.

[16]  B. Aggarwal,et al.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.

[17]  P. Lollini,et al.  IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTS , 1983, Journal of immunogenetics.

[18]  G. Klein,et al.  Lung colonization and metastasis by disseminated b16 melanoma cells: H‐2 associated control at the level of the host and the tumor cell , 1985, International journal of cancer.

[19]  S. Silagi,et al.  Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones , 1984, Somatic cell and molecular genetics.

[20]  S. Segal,et al.  MHC imbalance and metastatic spread in Lewis lung carcinoma clones , 1983, International journal of cancer.

[21]  P. Lollini,et al.  Interferon-mediated enhancement of metastasis. Are MHC antigens involved? , 1987, Clinical & Experimental Metastasis.